EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

In-hospital costs of coronary stent implantation with and without eptifibatide



In-hospital costs of coronary stent implantation with and without eptifibatide



American Journal of Cardiology 89(1): 61-64, January 1




(PDF emailed within 1 workday: $29.90)

Accession: 035111630

Download citation: RISBibTeXText



Related references

In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. American Journal of Cardiology 89(1): 61-64, 2002

Effect of Eptifibatide on coronary flow reserve following coronary stent implantation (An ESPRIT substudy). American Journal of Cardiology 87(11): 1293-1295, 2001

Eptifibatide in coronary stent implantation Long-term results of the ESPRIT trial. Circulation 104(17 Supplement): II 94, October 23, 2001

Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy. American Journal of Cardiology 87(11): 1293-1295, 2001

High-dose eptifibatide in elective coronary stent implantation Results of the ESPRIT trial. European Heart Journal 21(Abstract Supplement): 146, August-September, 2000

High-dose eptifibatide in coronary stent implantation 6 Month results of the ESPRIT trial. Circulation 102(18 Supplement): II 663, October 31, 2000

High-dose eptifibatide in coronary stent implantation 1 Year results of the ESPRIT trial. Journal of the American College of Cardiology 37(2 Supplement A): 76A, February, 2001

Treatment effect at different levels of creatinine clearance following eptifibatide in planned coronary stent implantation. Journal of the American College of Cardiology 37(2 Supplement A): 11A, February, 2001

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 356(9247): 2037-2044, 2001

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized placebo-controlled study. Indian Heart Journal 53(3): 376-376, 2001

Adjunctive therapy with eptifibatide administered as a double bolus plus infusion in a patient undergoing elective implantation of a coronary stent. Journal of Invasive Cardiology 12 Suppl D: 8d-9d, 2001

Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). American Journal of Cardiology 91(1): 17-21, 2002

Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT trial). American Journal of Cardiology 91(1): 17-21, 2003

Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods. 2007

Quantifying the additional costs of stent implantation in the aspirin/ticlopidine era Analysis of device utilization and in-hospital costs for 291 consecutive elective interventions. European Heart Journal. 18(abstr. Suppl.): 472, 1997